A tragic incident unfolded at the Alto Vale Regional Hospital in Rio do Sul, Brazil, when a 22-year-old lawyer, Leticia Paul, suffered a fatal allergic reaction during a routine CT scan. The young lawyer was undergoing a contrast-enhanced CT scan on Wednesday when the contrast dye used in the procedure triggered a severe anaphylactic shock, leading to her untimely demise.
Anaphylactic shock is a severe allergic reaction that can result in life-threatening conditions such as airway constriction, throat swelling, and a significant drop in blood pressure, among other symptoms. Immediate medical intervention is crucial to prevent fatal outcomes, according to medical experts at the Cleveland Clinic.
Paul’s family shared that she was immediately rushed to the hospital following the reaction. However, despite the swift response, she succumbed to the reaction less than a day after the procedure. Paul had been battling kidney stones, and the CT scan was part of her routine medical checkup.
Following her tragic passing, Paul was cremated at the Vatican Crematorium in Balneário Camboriú. The young lawyer had recently graduated from Colégio Sinodal Ruy Barbosa’s law program and was pursuing postgraduate studies in Law and Real Estate. The school expressed their condolences to her family and friends, offering them strength during this challenging time.
In the wake of the incident, the Alto Vale Regional Hospital expressed their regret and solidarity with Paul’s family. The hospital reiterated its commitment to ethics, transparency, and patient safety, stating that all procedures had been carried out in line with recommended clinical protocols.
Contrast dyes, often iodinated, are routinely used during CT scans, MRIs, and X-rays to enhance the clarity of images of organs and tissues. The National Library of Medicine states that these dyes are generally safe, with life-threatening reactions occurring in only about one in every 5,000 to 10,000 patients. Most people experience mild symptoms such as a brief flush of warmth, mild nausea, or itching after the injection.